$473.4 M

PACB Mkt cap, 18-Jul-2018

$19.4 M

Pacific Biosciences of California Revenue Q1, 2018
Pacific Biosciences of California Gross profit (Q1, 2018)7.3 M
Pacific Biosciences of California Gross profit margin (Q1, 2018), %37.7%
Pacific Biosciences of California Net income (Q1, 2018)-24.2 M
Pacific Biosciences of California EBIT (Q1, 2018)-23.9 M
Pacific Biosciences of California Cash, 31-Mar-201825.5 M

Pacific Biosciences of California Revenue

Pacific Biosciences of California revenue was $93.47 m in FY, 2017

Embed Graph

Pacific Biosciences of California Revenue Breakdown

Embed Graph

Pacific Biosciences of California revenue breakdown by geographic segment: 21.9% from Asia, 22.1% from Europe and 56.0% from North America

Pacific Biosciences of California Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

28.2 m60.6 m92.8 m90.7 m93.5 m

Revenue growth, %

115%53%(2%)

Cost of goods sold

21.8 m37.2 m39.3 m46.6 m58.8 m

Gross profit

6.4 m23.4 m53.5 m44.2 m34.7 m

Gross profit Margin, %

23%39%58%49%37%

R&D expense

67.6 m65.3 m

General and administrative expense

59.1 m

Operating expense total

67.6 m124.4 m

EBIT

(77.5 m)(62.9 m)(29.1 m)(71.2 m)(89.8 m)

EBIT margin, %

(275%)(104%)(31%)(79%)(96%)

Interest expense

2.5 m2.8 m2.9 m3.2 m2.9 m

Net Income

(79.3 m)(66.2 m)(31.7 m)(74.4 m)(92.2 m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

7.4 m11.6 m11.4 m20.6 m17.6 m24.9 m13.9 m19.1 m20.7 m25.1 m24.9 m20.1 m19.4 m

Cost of goods sold

6.2 m9 m8.3 m7.5 m11.7 m10.4 m7.4 m9.6 m10.1 m12.5 m16 m12.1 m12.1 m

Gross profit

1.2 m2.7 m3.1 m13.2 m5.9 m14.5 m6.6 m9.5 m10.6 m12.6 m8.9 m8 m7.3 m

Gross profit Margin, %

17%23%27%64%34%58%47%50%51%50%36%40%38%

R&D expense

10.4 m11.8 m12.4 m11.7 m14.5 m15 m16.2 m16.4 m17.5 m17.5 m17 m16.9 m16.3 m

General and administrative expense

14.9 m

Operating expense total

21.2 m20.9 m21.4 m21.6 m25.3 m25.9 m3.9 m28.1 m28.7 m29.4 m32.2 m32.4 m31.2 m

EBIT

(19.9 m)(18.2 m)(18.3 m)(8.4 m)(19.3 m)(11.4 m)(18.6 m)(18.1 m)(16.7 m)(23.3 m)(24.4 m)(23.9 m)

EBIT margin, %

(269%)(157%)(160%)(41%)(110%)(46%)(97%)(87%)(67%)(94%)(121%)(124%)

Interest expense

686 k686 k701 k716 k697 k715 k741 k779 k795 k821 k838 k826 k581 k

Net Income

(20.5 m)(18.9 m)(19.1 m)(9.2 m)(20.2 m)(11.9 m)1.8 m(19.4 m)(18.5 m)(17.5 m)(23.9 m)(25.5 m)(24.2 m)

Pacific Biosciences of California Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

26.4 m36.4 m33.6 m16.8 m16.5 m

Accounts Receivable

2.7 m3.4 m5.2 m11.4 m13.4 m

Inventories

1.1 m1.7 m12.1 m15.6 m23.1 m

Current Assets

126.5 m117.8 m110.5 m109 m101.6 m

PP&E

9.2 m6.6 m8.5 m14.6 m37.9 m

Total Assets

136.2 m124.5 m131.1 m137.9 m144.1 m

Accounts Payable

1.7 m5.6 m4.7 m8.4 m9.1 m

Short-term debt

14.1 m14.9 m16.1 m

Current Liabilities

22.6 m31.5 m38.2 m33.8 m28.6 m

Long-term debt

14.1 m14.9 m16.1 m

Total Debt

28.2 m29.9 m32.2 m

Total Liabilities

53.2 m58 m

Additional Paid-in Capital

684.4 m736.3 m786.6 m872.1 m965.8 m

Retained Earnings

(615.3 m)(681.5 m)(713.2 m)(787.5 m)(879.7 m)

Total Equity

69.2 m54.9 m73.5 m84.7 m86.1 m

Debt to Equity Ratio

0.5 x0.4 x0.4 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x

Financial Leverage

2 x2.3 x1.8 x1.6 x1.7 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

64.8 m41.3 m28.2 m35.4 m30.3 m25.9 m27.2 m20.1 m24.8 m22.8 m29 m36.5 m25.5 m

Accounts Receivable

3.8 m3.4 m4.3 m2.4 m5.3 m4 m4.2 m8 m10.4 m11.8 m10.4 m9.5 m8.5 m

Inventories

9.8 m8.3 m9.4 m11.4 m13.5 m12 m11.6 m12.2 m14.2 m16.5 m15.3 m17.3 m25.9 m

Current Assets

141.8 m132.1 m119.9 m114.1 m99.5 m90.2 m86.2 m119.1 m138.1 m122.5 m88.3 m132.9 m115.7 m

PP&E

10.5 m8.5 m7.9 m7 m6.7 m6.4 m7.9 m9.1 m11.2 m14 m42.4 m40.3 m36.7 m

Total Assets

152.8 m141 m128.2 m121.6 m106.4 m96.8 m99.8 m140.2 m161.4 m150.6 m135.5 m177.9 m156.9 m

Accounts Payable

3.4 m3.9 m5.4 m5.8 m6.9 m5.8 m6.1 m4.7 m5.4 m8.3 m8.2 m6.5 m8.6 m

Short-term debt

13.2 m13.5 m13.7 m13.9 m14.3 m14.6 m14.8 m15.2 m15.5 m15.8 m

Current Liabilities

22.5 m22.5 m28 m29.1 m38.4 m39 m38.8 m32 m33.8 m32.1 m35.4 m35.7 m24.9 m

Long-term debt

13.2 m13.5 m13.7 m13.9 m14.3 m14.6 m14.8 m15.2 m15.5 m15.8 m

Total Debt

26.3 m27.1 m27.4 m27.8 m28.7 m29.1 m29.6 m30.4 m31 m31.6 m

Total Liabilities

69.3 m65.5 m69.2 m68.6 m65.9 m62.9 m58.4 m51.4 m53.3 m52 m66.3 m62 m54.2 m

Additional Paid-in Capital

709.6 m712.2 m715.4 m742 m747.3 m753 m821.2 m858.9 m867.1 m880.5 m952.7 m1 b

Retained Earnings

(598.1 m)(634.2 m)(653.3 m)(662.5 m)(701.6 m)(713.6 m)(711.8 m)(732.5 m)(751 m)(768.5 m)(811.4 m)(837 m)(903.7 m)

Total Equity

83.5 m75.5 m59 m53 m40.5 m33.8 m41.4 m88.8 m108.1 m98.7 m69.2 m115.9 m102.7 m

Financial Leverage

1.8 x1.9 x2.2 x2.3 x2.6 x2.9 x2.4 x1.6 x1.5 x1.5 x2 x1.5 x1.5 x

Pacific Biosciences of California Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(79.3 m)(66.2 m)(31.7 m)(74.4 m)(92.2 m)

Depreciation and Amortization

5.6 m4.2 m3.7 m3.9 m8.4 m

Accounts Receivable

76 k(660 k)(1.7 m)(6.2 m)(2 m)

Inventories

(60 k)(1.3 m)(2.5 m)(6.2 m)(8.4 m)

Accounts Payable

(1.3 m)3.9 m(716 k)3.4 m764 k

Cash From Operating Activities

(29.8 m)(51.5 m)(47.9 m)(67.9 m)(67.5 m)

Purchases of PP&E

(909 k)(1.6 m)(3 m)(8.2 m)(10.4 m)

Cash From Investing Activities

(33.1 m)19.6 m8.6 m(14.9 m)(1.5 m)

Cash From Financing Activities

42.8 m42 m36.5 m65.9 m68.8 m

Interest Paid

1.2 m1.8 m1.8 m1.8 m1.7 m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(20.5 m)(18.9 m)(19.1 m)(9.2 m)(20.2 m)(11.9 m)1.8 m(19.4 m)(18.5 m)(17.5 m)(23.9 m)(24.2 m)

Depreciation and Amortization

1.8 m

Accounts Receivable

4.3 m2.4 m5.3 m4 m4.2 m8 m10.4 m11.8 m10.4 m5 m

Inventories

13.5 m12 m11.6 m12.2 m14.2 m16.5 m15.3 m(2.7 m)

Accounts Payable

5.4 m5.8 m6.9 m5.8 m6.1 m4.7 m5.4 m8.3 m8.2 m(942 k)

Cash From Operating Activities

(18.8 m)

Purchases of PP&E

(344 k)

Cash From Investing Activities

(7.7 m)

Cash From Financing Activities

35.5 m

Pacific Biosciences of California Ratios

USDY, 2018

Revenue/Employee

44.2 k

Financial Leverage

1.5 x
Report incorrect company information

Pacific Biosciences of California Operating Metrics

FY, 2016

Patents (US)

221

Patents (foreign)

133

Patents Pending

187
Report incorrect company information